Alpha Pro Tech Ltd. - Q1 2011 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2011. Alpha Pro Tech Ltd. operates in three segments: Disposable Protective Apparel, Building Supply, and Infection Control. The company manufactures and markets products for cleanroom, industrial, pharmaceutical, medical, and construction markets. During the quarter, the company divested its medical bed pad and pet bed product lines.
Key Financial Metrics
| Metric | Q1 2011 | Q1 2010 |
|---|---|---|
| Net Sales | $8,945,000 | $11,629,000 |
| Gross Profit | $3,273,000 | $4,988,000 |
| Gross Margin | 36.6% | 42.9% |
| Operating Income (Loss) | $(352,000) | $997,000 |
| Net Income (Loss) | $(112,000) | $687,000 |
| Cash and Cash Equivalents (End of Period) | $2,817,000 | $5,428,000 |
| Working Capital | $29,891,000 | N/A |
| Debt (Long-term) | $0 | $0 |
Liquidity: The company maintains a $3.5 million credit facility with Wells Fargo Bank, which was undrawn as of March 31, 2011. The current ratio was 41:1.
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 23.1% year-over-year. The Disposable Protective Apparel segment saw a 42.8% drop due to a former largest distributor launching a competing private label line. The Infection Control segment declined 29.2% due to similar distributor competition and the divestiture of bed pads/pet beds.
- Profitability Reversal: The company reported a net loss of $112,000 compared to net income of $687,000 in the prior year. Operating income turned negative ($352,000 loss) due to the significant drop in gross profit.
- Cash Flow: Net cash used in operating activities was $2.7 million, primarily driven by a $2.2 million increase in accounts receivable due to extended payment terms granted to Building Supply customers.
- Asset Divestiture: The company sold its pet bed and medical bed pad lines for $235,000, recognizing a net gain of $41,000.
Outlook, Risks, and Management Commentary
- Guidance: Management expects gross margins to increase by approximately one percentage point in coming quarters. Days sales outstanding (currently 60 days) are expected to return to normal levels (33 days) in Q2 2011.
- Product Strategy: The company launched "REX Wrap Fortis" housewrap in Q4 2010, expecting it to contribute significantly to sales starting in Q2 2011. The Building Supply segment remains a growth focus despite a weak housing market.
- Risks: Key risks include continued loss of market share to competitors launching private label lines and the impact of weather on construction-related sales. The company has no material foreign currency exposure as transactions are settled in USD.
- Capital Allocation: The company has $2.86 million remaining under its stock repurchase plan but did not repurchase shares in Q1 2011.
Investor Verification Checklist
- Verify the recovery of accounts receivable days sales outstanding in Q2 2011 to confirm cash flow improvement.
- Monitor the sales performance of the new REX Wrap Fortis product line.
- Assess the stability of the Disposable Protective Apparel segment following the loss of the major distributor.
- Confirm the renewal of the $3.5 million Wells Fargo credit facility expiring in May 2011.
- Review the impact of the divestiture of the Infection Control bed pad/pet bed lines on future segment reporting.